TCL Archive Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence December 26, 2008
TCL Archive Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control July 18, 1975
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014